You are subscribed to the FormularyWatch.

Formulary

eNewsletter Subscribe

May 11, 2015

Web Version  | Share with a colleague

Facebook Like Twitter Tweet

Today's Headlines

Patients gain power over pain, plus 4 more FDA approvals

Patients who are recovering from surgery in the hospital can control their analgesic dosing with Ionsys, a fentanyl opioid ssytem, that delivers pain medicine, plus 4 more new therapies approved by FDA. » Read more

Belatacept demonstrates positive survival benefit in long-term open-label follow-up

New data from the 2015 American Transplant Congress in Philadelphia, showed a statistically significant 43% relative risk reduction of death or transplant failure in patients receiving the belatacept (Nulojix) FDA-approved dosing regimen over those receiving a cyclosporine regimen. » Study details

Continuing Education

MTM essentials for asthma management: Part 2

This month's CE activity is part of the CE series, MTM for the Patient with Respiratory Disease. From April 2015 through December 2015, pharmacists can earn up to 18 hours of CPE credit with 9 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to review the stepwise approach to the management of pediatric and adult asthma and the pharmacotherapies commonly used in asthma treatment.

To read and print the article with TEST questions, click here

To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the Session Code: 15DT30-PYJ23.


Announcement: The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration has been uploaded for your convenience. Current users do not need to register. To review you registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

EDITOR'S PICK

CPNP offers dispensing, education guide for naloxone

Naloxone is a lifesaving antidote for reversing opioid overdose symptoms and the pharmacist’s role has quickly expanded in managing this population. » 4 things to remember about naloxone

 

RELATED ARTICLES

FDA moves forward with approval of generic Abilify from 4 different manufacturers despite Otsuka pushback

IPF survival rates better in double-lung transplantation

RESOURCES

Latest Clinical News

Powered by Modern Medicine UBM  logo

UBM MEDICA